|
|
 |
Investment Portfolio
Athenix, Inc
Athenix is a leading biotechnology company that discovers and develops novel products, technologies and processes for the agricultural and chemical businesses.
The company provides genes, proteins, traits, and transgenic organisms for multiple industry sectors including seed, agricultural chemicals, specialty chemicals, industrial enzymes, energy and feed.
Athenix, Inc. has entered into an agreement with Bayer Crop Sciences to acquire the company. This successful "exit" in the current economic environment is a pleasing result for both the company and investors. See the press release on the transaction.
Athenix is located in Durham, North Carolina, US.
Catharos Medical Systems, Inc
Catharos is an early stage medical device company that is focused on preventing contrast induced nephropathy ("CIN") by removing radio-contrast dye injected during catheterizations from the patient's body prior to the dye reaching the kidneys.
Catharos is based in Los Gatos, California, US.
Generic Medical Devices (GMD), Inc
GMD'S mission is to improve the lives of patients, families and health care providers by offering high quality, cost effective medical devices for standard of care procedures. GMD is initially focused on soft tissue repair products and products used in soft tissue repair procedures. GMD's first two products will be a universal sling kit for female stress urinary incontinence and a complete line of ventral and inguinal hernia repair mesh.
GMD is headquartered in Gig Harbor, Washington State, near Seattle. The company's European office is in Brussels, Belgium.
Hawaii Bio Energy, LLC
Hawaii BioEnergy was established by three of Hawaii’s largest landowners, Kamehameha Schools, Grove Farm and Maui Land & Pineapple. They were joined by leading investors from the venture community including Khosla Ventures, Finistere Ventures and Ohana Holdings, and investment entity owned by Pierre Omidyar, founder of eBay. The company is focused on providing biomass-based renewable energy solutions that reduce Hawaii’s reliance on imported fuels for its utilities and transport, and improve the fuel security of the Islands particularly working with the military sector. The company has access to significant landholdings and has formed technology alliances in renewable energy technologies that include novel energy crops like algae as well as process conversion technologies. The company’s business model is to develop investment grade projects and establish partnerships necessary to create operating businesses in renewable energy with a focus on Hawaii.
Hawaii Bio Energy is headquartered in Honolulu, Oahu, US.
For the official press release and news on Finistere's role in the latest investment round, click here.
For more about Hawaii Bio Energy, click here to read the New York Times article.
Hotspur, Inc.
Hotspur is developing a portfolio of percutaneous product solutions specifically designed to address issues associated with hemodialysis access. In 2012, Hotspur was acquired by Teleflex (TFX), a leading provider of medical devices for critical care and surgery. See more at http://inceptllc.com/news/teleflex-acquires-hotspur-technologies-inc
Hotspur is located in Mountain View, California.
Luminous Medical, Inc
Luminous Medical is developing an automated glucose measurement system that addresses the rapidly growing clinical demand for tight glycemic control ("TGC") in the intensive care unit, operating room and intermediate care units.
For the official press release and news on Finistere's role in the latest investment round, see www.luminousmedical.com/news.html
Luminous is located in Carlsbad, CA.
nContact Surgical, Inc.
nContact Surgical is an early stage medical device company focused on providing new tissue coagulation devices used during surgical procedures for the treatment of atrial fibrilation.
nContact is located in Morrisville, North Carolina, US.
Sadra Medical, Inc.
Sadra Medical is developing innovative percutaneous therapies for the treatment of aortic valve disease that will provide a less invasive alternative to traditional surgical valve replacement.
In April 2011, Sadra Medical was acquired by Boston Scientific for a total transaction value of $450M with $225M paid upfront. For more on the official press release see the Company announcement at http://www.bostonscientific.com/templatedata/imports/HTML/sadra-medical/news.html
Somark Innovations, Inc.
Somark has developed a novel tattoo and reading system which allows for unique animal identification, with the first target market being laboratory animals. In December 2012, Somark Innovations was acquired by Labstamp International Ltd, an Australian based Company, to enable global distribution and funding of sales expansion. SOMARK is located in San Diego, CA.
Transcend Medical, Inc.
Transcend Medical, Inc. is developing novel devices that will allow for a less invasive and more effective treatment of glaucoma.
Transcend is located in Menlo Park, CA.
SG Biofuels (SGB).
SGB is a fully integrated bioenergy crop company using molecular breeding and biotechnology to develop and produce elite hybrid seeds of Jatropha as a low-cost feedstock for biodiesel, bio jet fuel and specialty chemicals.
With the largest and most diverse library of Jatropha genetic material, SGB is turning the opportunities of Jatropha into reality through a world-class leadership team, leading-edge science and genetics and expertise in agronomy and plantation management.
SGB has been named one of the *Top 5 Renewable Jet Fuel Supply Chain Companies in the World by The Carbon War Room* (2011), one of the *Top 50 Companies in Bioenergy* for three consecutive years (2009, 2010 and 2011) and the *2010 Feedstock Domestication Project of the Year by Biofuels Digest* and one of the *Top 200 Going Green Private Companies in the World by Always On*.
Finistere Ventures participated in the January 2012 financing of a Series B round of USD $17M along with Thomas, McNerney Partners. Click here to see the attached press release.
In 2013, SGB announced its plans for a new Series C round of financing to further develop its global deployment of JMAX Knowledge Centers, further its world class breeding program and molecular biology platform, as well as initiate the development of its first customer Jatropha Plantation.
SGB announced its Series C financing for $30M and significant new customer activity in Brazil. Download the SGB Press Release January 2013 for more information.
ZeaKal Inc.
ZeaKal is a plant science company commercializing the portfolio across a number of established row crops such as corn, soybeans and canola. The rapid adoption of first generation biotech has vastly improved yields, not to mention additional environmental benefits from lower pesticide use. Although these crops are already intensely farmed, the adoption of ZeaKal's second generation traits will allow for further productivity gains that cannot be achieved through breeding, chemistry and agronomics alone.
